Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-25-000112
Filing Date
2025-01-02
Accepted
2025-01-02 16:38:35
Documents
2
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form3-01022025_090131.html 3  
1 form3-01022025_090131.xml 3 11006
2 ex24-01022025_090132.htm EX-24 5226
  Complete submission text file 0001415889-25-000112.txt   17633
Mailing Address C/O CALLISTO PHARMACEUTICALS, INC. 420 LEXINGTON AVE., SUITE 1609 NEW YORK NY 10170
Business Address
Ross Iain (Reporting) CIK: 0001307218 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39487 | Film No.: 25502586

Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)